This review article explores the role of immuno-radiotherapy in the context of genome instability and tumour evolution. Genomic changes in tumours exist in a delicate balance with the immune system, offering evolutionary pathways to adapt and grow but risking provoking an immune response. Rapid developments across both immunotherapy and radiotherapy have raised questions about the potential benefits combination therapy, and how best to identify ideal treatment populations. Here we discuss foundational studies of genomic instability and tumour evolution, how these paradigms translate into immune surveillance and evasion, and subsequently go on to explore recent preclinical and clinical studies of both treatment modalities. Understanding how cancers evolve in the context of the immune system could provide a key insight in delivering better therapies that could overcome treatment resistance.
Tumour Evolution Driving Genome Instability, Immune Interactions, and Response to Radiotherapy
G. Seed,France Truong,Rahma Riahi,Ben O'Leary
Published 2025 in Cancer Journal
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Cancer Journal
- Publication date
2025-06-09
- Fields of study
Biology, Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-1 of 1 citing papers · Page 1 of 1